Enforcement: Opioid Fraud Continues to Run Rampant, Report Shows

Why This Topic Matters

The article helps readers understand current federal enforcement priorities and the breadth of fraud and abuse activity being pursued by OIG and its partners. It also signals the kinds of compliance risks and program vulnerabilities that continue to draw scrutiny across federal healthcare programs.

Article Sections

1. Nuts and bolts

   Overview of the report’s scope, time period, and the broad enforcement themes highlighted by OIG.

2. Take a Look at the Enforcement Numbers

   Summary of the report’s audit, recovery, investigative, criminal, civil, and exclusion activity, along with OIG’s resource concerns.

3. Check Out These Top Takedowns

   High-level discussion of selected enforcement matters involving home health, substance use disorder treatment, prescription drugs, and kickback-related conduct.